IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-6757

  1. 1,958 Posts.
    lightbulb Created with Sketch. 4359
    It's nearly party time ?

    Time to bring out some balloons cool.png

    A considerable difference in the Balloons for the Psychedelics Trial with a massive up ramping for GAD.

    I think this has gone a little under the radar in the discussion here so far.

    "The Company is now in the process of co-ordinating two clinical trials as part of the clinical development program aimed at achieving FDA approval for Psi-GAD therapy "

    The latest Activities report noted that they have decided to split the 1st GAD Trial into two phases
    1st Part will be 30 of the total 72 patients
    2nd Part will be the remaining 42 of the 72 patients

    After the 1st phase is completed it will enable a review of the data to inform the 2nd Phase of the Trial
    and or

    The 2nd Phase 2b Trial which Incannex are actively planning.
    "Preparations for this larger, pivotal, multi-site phase 2b clinical trial are continuing"

    We saw how how the BOD added a W.A. Trial to the Sleep Apnoea Trial in order to be compliant with the FDA multi-site evidence gathering requirement, seems they are preparing for the same with the GAD Trial.

    The additional LARGER, MULTI-SITE Phase 2 Trial has been added.

    More news flow for the North American Market folks! wink.png

    CLICK THIS UPDATED IMAGE FOR A LARGER VIEW

    https://hotcopper.com.au/data/attachments/3418/3418659-b29400d85e412402075278d67c1d71b1.jpg


 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.